2390 |
Kario K., Park S., Chia Y.-C., Sukonthasarn A., Turana Y., Shin J., Chen C.-H., Buranakitjaroen P., Divinagracia R., Nailes J., Hoshide S., Siddique S., Sison J., Soenarta A.A., Sogunuru G.P., Tay J.C., Teo B.W., Zhang Y.-Q., Van Minh H., Tomitani N., Kabutoya T., Verma N., Wang T.-D., Wang J.-G. |
2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network |
2020 |
Journal of Clinical Hypertension |
48 |
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, South Korea; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Selangor Darul Ehsan, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya Kuala, Lumpur, Malaysia; Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines; Fatima Memorial Hospital, Lahore, Pakistan; Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Department of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore; Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore; Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; King George's Medical University, Uttar Pradesh, Chowk, Lucknow, India; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Abbott Laboratories; Pfizer; Bayer; Novartis; Sanofi; Boehringer Ingelheim; Takeda Pharmaceutical Company; Merck Sharp and Dohme; Horizon Pharma; GlaxoSmithKline Japan; Fund for Innovation in Cancer Informatics; Daiichi-Sankyo; Canadian Council on Learning; Servier; Orient Europharma |
Blackwell Publishing Inc. |
Q2 |
|
|